RinoFluimucil 1% + 0.5% N-Acetylcysteine Rhinitis Nasal Spray 10 ml

€8.80
Tax included
Minsan
021993050
100% secure payments
Hurry up! Only 47 item(s) left in Stock!
Quantity

WARNINGS
In patients with cardiovascular diseases, and especially in hypertensive patients, the use of nasal decongestants must be subjected to the judgment of the physician from time to time. Administer with caution in subjects suffering from occlusive vascular disease, asthma, diabetes and in therapy with beta-blocking drugs. The medicine should be administered with caution in pediatric age and is in any case contraindicated in children younger than 12 years. The prolonged use of preparations containing vasoconstrictors can alter the normal function of the mucous membrane of the nose and paranasal sinuses, also inducing addiction to the drug. Repeating applications for long periods can therefore be harmful. Use the product with caution, due to the risk of urinary retention, in the elderly and in patients with prostatic hypertrophy. The use, especially if prolonged, of topical products can give rise to sensitization phenomena: in this case it is necessary to stop the treatment and, if necessary, to institute a suitable therapy. However, in the absence of a complete therapeutic response within a few days, consult your doctor; in any case, the treatment must not be continued for more than a week. The action of the preparation can be integrated, in the opinion of the doctor, with an appropriate antibacterial cover. Tuaminoheptane sulfate can determine a positive doping test. The preparation is not for ophthalmic use. Important information about some of the excipients The preservative benzalkonium chloride can cause skin reactions or bronchospasm.
PHARMACOTHERAPEUTIC CATEGORY
Rhinological preparations - decongestants-sympathomimetics.
STORAGE
No particular precautions for storage.
CONTRAINDICATIONS / SECONDARY EFFECT
Hypersensitivity 'to the active substance or to any of the excipients. Narrow angle glaucoma. Hyperthyroidism. During and in the two weeks following therapy with monoamine oxidase inhibitors (MAOIs). Children under the age of 12. Pheochromocytoma. During the use of other sympathomimetic agents, including other nasal decongestants. Hypophysectomy or surgery with exposure of the dura mater.
NAME
RINOFLUIMUCIL 1% + 0.5% NASAL SPRAY SOLUTION
EXCIPIENTS
Benzalkonium chloride, dithiothreitol, sodium edetate, dibasic sodium phosphate, monobasic sodium phosphate, sodium hydroxide, alcohol, hypromellose, 70% sorbitol, natural mint flavor, purified water.
SIDE EFFECTS
Frequent administration of the preparation at higher doses can cause sympathomimetic side effects (such as increased excitability, heartbeat, tremor, etc.). Dry nose and throat, acne eruptions can sometimes occur. These effects disappear completely when the treatment is stopped. Immune system disorders: hypersensitivity '. Psychiatric disorders: anxiety, hallucination, delirium. Nervous system disorders: headache, restlessness, agitation, insomnia, tremor. Cardiac disorders: palpitations, tachycardia, arrhythmia. Vascular disorders: hypertension. Respiratory, thoracic and mediastinal disorders: nasal and throat dryness, nasal discomfort, nasal congestion. Gastrointestinal disorders: nausea, skin and subcutaneous tissue disorders: urticaria, rash. Renal and urinary disorders: urinary retention. General disorders and administration site conditions: irritability, drug addiction.
PREGNANCY AND BREASTFEEDING
Data from a limited number of pregnant women exposed to N-acetylcysteine did not indicate any adverse effects on the pregnancy itself or on the health of the fetus / newborn. At present, no further relevant epidemiological data are available. Animal studies have not shown direct or indirect harmful effects with respect to reproductive toxicity. There are no data on pregnant women exposed to youraminoheptane or animal studies with youramonoheptane. The drug is not recommended in pregnancy. There is no information available on the excretion of N-acetylcysteine and tuaminoheptane in breast milk therefore the product should not be used by breastfeeding mothers.
INDICATIONS
Acute and subacute rhinitis, especially with slow-resolving mucopurulent exudates. Chronic and mucus-crusted rhinitis. Vasomotor rhinitis. Sinusitis.
INTERACTIONS
Despite the poor systemic absorption of intranasally administered tuaminoheptane, the following potential interactions should be considered. Monoamine oxidase inhibitors (MAOIs), including reversible monoamine oxidase inhibitors (RIMA): increased risk of hypertensive crisis; antihypertensives (including adrenergic neuron blockers and beta blockers): can block hypotensive effects; cardiac glycosides: can increase the risk of dysrhythmia; ergot alkaloids: may increase the risk of ergotism; antiparkinsonian drugs: can increase the risk of cardiovascular toxicity; oxytocin: can 'increase the risk of hypertension.
DOSAGE
The medicine is used for applications in the nasal cavities, using the appropriate dosage dispenser. Adults: 2 sprays in each nostril 3-4 times a day. Children over 12 years: 1 pump in each nostril 3-4 times a day. Do not exceed the indicated doses. The bottle, when opened, can be used for a period not exceeding 20 days.
ACTIVE PRINCIPLES
100 ml of solution contain: N-Acetylcysteine 1,000 g, tuaminoheptane sulfate 0,500 g.
021993050
47 Items

Specific References

chat Comments (0)
No customer reviews for the moment.

RinoFluimucil 1% + 0.5%...

€8.80